Lantern Pharma Newsroom

Is Lantern Pharma (NASDAQ:LTRN) In A Good Position To Invest In Growth?

Yahoo FinanceDec 22 22:11

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 14 05:06

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation From FDA For Treatment Of Triple Negative Breast Cancer

BenzingaDec 3 21:12

Express News | Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation From FDA for Treatment of Triple Negative Breast Cancer (Tnbc)

BreakingsDec 3 21:00

Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality

BusinesswireNov 26 21:45

Express News | Lantern Pharma & Starlight Therapeutics Present LP-184 (Star-001) Phase 1B Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (Sno) 2024 Highlighting Novel Synthetic Lethality

BreakingsNov 26 21:45

Express News | Lantern Pharma Announces First Patient Dosed in Japan for the Expansion Cohort in the Phase 2 Harmonic™ Clinical Trial of LP-300 in Never-Smoker Nsclc Patients

BreakingsNov 19 21:00

Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 9 08:23

Lantern Pharma Advances AI-Driven Cancer Therapies

TipRanksNov 8 12:48

Lantern Pharma 3Q Loss/Shr 42c >LTRN

Dow JonesNov 8 06:37

Lantern Pharma | 10-Q: Q3 2024 Earnings Report

SECNov 8 05:14 · Announcements

Lantern Pharma | 8-K: Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates

SECNov 8 05:08

Express News | Lantern Pharma Q3 Net Income USD -4.5 Million

BreakingsNov 8 05:05

Express News | Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board

BreakingsNov 5 21:00

Earnings Preview: LTRN to Report Financial Results Post-market on November 07

$Lantern Pharma(LTRN.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Lantern Pharma(LTRN.US)$ to post revenue of USD0 for 2024Q3,

Futu NewsNov 1 20:45

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024

BusinesswireOct 23 20:45

Lantern Pharma to Host & Participate in Two Public Webinars During October

Yahoo FinanceOct 21 20:00

Express News | Lantern Pharma Inc - Phase 1B/2a Trial for Recurrent GBM to Start Late 2024

BreakingsOct 15 21:07

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA

BusinesswireOct 15 21:07

Express News | Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA

BreakingsOct 15 21:07